Incremental cost-effective ratio effect of Omalizumab treatment for Severe Allergic Asthma at Danish university Hospital

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	PA400
Journal	European Respiratory Journal
Volume	52
Issue number	Suppl. 62
ISSN	0903-1936
DOIs	https://doi.org/10.1183/13993003.congress-2018.PA4000
Publication status	Published - 2018
Event	ERS International Congress 2018 - Paris, France Duration: 15 Sept 2018 → 19 Sept 2018 https://erscongress.org/

Abstract no. PA1205

Access to Document

@article{6f885f9c9853462b86c1ee1fb8572841,

title = "Incremental cost-effective ratio effect of Omalizumab treatment for Severe Allergic Asthma at Danish university Hospital",

author = "{Bagge Petersen}, S{\o}ren and Weinreich, {Ulla M{\o}ller}",

note = "Abstract no. PA1205; ERS International Congress 2018 ; Conference date: 15-09-2018 Through 19-09-2018",

year = "2018",

doi = "10.1183/13993003.congress-2018.PA4000",

language = "English",

volume = "52",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "Suppl. 62",

url = "https://erscongress.org/",

}

TY - ABST

T1 - Incremental cost-effective ratio effect of Omalizumab treatment for Severe Allergic Asthma at Danish university Hospital

AU - Bagge Petersen, Søren

AU - Weinreich, Ulla Møller

N1 - Abstract no. PA1205

PY - 2018

Y1 - 2018

U2 - 10.1183/13993003.congress-2018.PA4000

DO - 10.1183/13993003.congress-2018.PA4000

M3 - Conference abstract in journal

SN - 0903-1936

VL - 52

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - Suppl. 62

M1 - PA400

T2 - ERS International Congress 2018

Y2 - 15 September 2018 through 19 September 2018

ER -